John Powers III brings decades of experience to the role, having contributed to the agency in clinical research positions since 1999 before stepping in as acting head in June. His confirmation stabilizes a post that remained vacant after Jeanne Marrazzo was removed by the Trump administration in March 2025. Following Marrazzo's exit, interim leader Jeffery Taubenberger abruptly resigned while multiple other top officials faced reassignments or resignation requests. The leadership shift unfolds as the agency continues confronting political pressure tied to former director Anthony Fauci.
Key points
The agency has officially solidified its top leadership following months of unexpected ad…: The agency has officially solidified its top leadership following months of unexpected administrative turnover.
Institutional stability returns as the organization navigates sustained political scrutin…: Institutional stability returns as the organization navigates sustained political scrutiny from the second Trump administration.
The new permanent director assumes control amid ongoing controversies surrounding past le…: The new permanent director assumes control amid ongoing controversies surrounding past leadership and funded research in China.
Sources checked by our analysis pipeline: 1
The acting director of the National Institutes of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday.
NIAID has been without a permanent director since March 2025, when the Trump administration ousted Jeanne Marrazzo. Powers has been serving in an acting capacity since June. A physician-scientist, Powers has worked with NIAID since 1999 in several roles focused on clinical research.
The second Trump administration has brought a renewed spotlight to the infectious disease institute, in large part because of the president’s ire for former director Anthony Fauci, and because of unsubstantiated accusations that research funded by the institute in China played a role in creating the SARS-CoV-2 virus. It has also seen tumult in its leadership. After Marrazzo was ousted, Jeffery Taubenberger was appointed acting director. He unexpectedly stepped down, and several other leaders at NIAID were reassigned to other institutes or asked to resign.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Emergency teams mobilised Tuesday morning after a passenger vehicle carrying dozens of travellers veered off a bridge near Gular Bazaar. Responders are working to extract victims from the steep ravine and transfer the wounded to medical facilities. The large-scale operation remains active as authorities coordinate relief efforts at the site.
Community members are expressing deep concern after the driver sustained severe injuries requiring medical intervention during a recent shift in Minnesota. The victim's family is demanding that law enforcement thoroughly investigate the motive behind the violent encounter. The incident has raised alarm among local immigrant rideshare operators regarding workplace safety.
Federal and international health officials are poised to declare that the United States has lost its measles elimination status, undoing a major public health achievement held for 26 years. This anticipated reversal stems from a sharp doubling of domestic infections over the past year, resulting in the nation's most severe measles outbreak in three decades. Medical professionals continue to urge immunization, affirming the exceptional reliability of standard preventative shots.